4 Mg Zoledronic Acid Injection IP

Name: 4 Mg Zoledronic Acid Injection IP
Brand: NEETCO BIOPHARMA
Price: 299 INR
Availability: InStock

Price 299 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

4 Mg Zoledronic Acid Injection IP Specification

Indication
Treatment of osteoporosis, hypercalcemia of malignancy, Pagets disease, bone metastases

Dosage Form
Injection (IV Infusion)

Salt Composition
Zoledronic Acid 4 mg

Enzyme Types
Not applicable (chemical pharmaceutical)

Feature
Single-dose vial, ready-to-use, sterile preparation

Ingredients
Zoledronic acid monohydrate, mannitol, sodium citrate, water for injection

Application
Bone health, management of high blood calcium, cancer-related bone disease

Ph Level
4.05.0 (approximate, buffer maintained)

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, do not freeze, protect from light

Shelf Life
24 months

Compatibility
Do not mix or infuse with other drugs

Packaging Type
Glass vial

Marketed By
As per image (not specified, refer to carton)

Contraindications
Hypersensitivity to zoledronic acid, severe renal impairment

Prescription Status
Prescription only

Administration Route
Intravenous infusion only

Strength
4 mg/5 mL

Precautions
Monitor renal function, calcium and electrolyte levels

Manufactured By
As per image (not specified, refer to vial labeling)

About 4 Mg Zoledronic Acid Injection IP

Experience a grand opportunity with our 4 Mg Zoledronic Acid Injection IP, available now at a phenomenal price cut. This rare clearance offer features a lofty standard of care for osteoporosis, hypercalcemia of malignancy, Paget's disease, and cancer-related bone disease. Each glass vial contains 4 mg/5 mL zoledronic acid, ensured sterile and stable for intravenous infusion, with a 24-month shelf life. Prescription exclusive, this clear, odorless solution is ready-to-use. Manufactured and marketed as per product labeling, perfect for distributors, exporters, and suppliers across India.

Usage and Administration of Zoledronic Acid Injection IP

4 Mg Zoledronic Acid Injection IP is strictly for prescription use, administered intravenously under healthcare supervision. It is specifically indicated for osteoporosis, hypercalcemia of malignancy, bone metastases, and Paget's disease. The single-use glass vial ensures aseptic preparation, and compatibility must be maintained by avoiding admixture with other medications. It plays a vital role in strengthening bone structure and regulating calcium levels, making it a key player in both acute interventions and long-term bone health management.

Sample Policy and Export Information

We offer express shipping and seamless freight options for sample requests, ensuring quick access for international clients. The product adheres to lofty certification standards suitable for global exchange, with main export markets spanning Asia, Africa, and the Middle East. Each shipment is handled with care and verified for compliance, supporting hassle-free re-exchange if required and guaranteeing top-tier product quality throughout the distribution process.

FAQ's of 4 Mg Zoledronic Acid Injection IP:

Q: How is 4 Mg Zoledronic Acid Injection IP administered?

A: This injection is administered by intravenous infusion only, under the supervision of qualified healthcare professionals in a clinical setting.

Q: What are the main indications for using this medication?

A: It is primarily used to treat osteoporosis, hypercalcemia associated with malignancy, Paget's disease, and bone metastases linked to cancer.

Q: When should renal function and electrolytes be monitored during treatment?

A: Renal function, as well as calcium and electrolyte levels, should be monitored before and during treatment, especially in patients at risk of renal impairment or electrolyte imbalance.

Q: Where should the injection be stored and for how long?

A: Store the injection below 30C, protected from light and never frozen. It has a shelf life of 24 months from the date of manufacture.

Q: What precautions should be considered before starting therapy?

A: Ensure patients are not hypersensitive to zoledronic acid and do not have severe renal impairment. Avoid mixing the product with other drugs during infusion.

Q: What are the benefits of using a single-dose, ready-to-use glass vial?

A: Single-dose vials ensure sterility, precise dosing, and easy administration, reducing contamination risk and simplifying the preparation process in clinical environments.

Tell us about your requirement